Zeyad Nasa

687 citations
21 papers · 538 indexed · h-index 13
Topics
Immune Cell Function and Interaction (4 papers)Immunotherapy and Immune Responses (4 papers)Virus-based gene therapy research (3 papers)
Journals
SHILAP Revista de lepidopterologíaThe Journal of ImmunologyPLoS ONE

In The Last Decade

Zeyad Nasa

21 papers receiving 527 citations

Peers

Zeyad Nasa
Comparison fields: 5 of 96
  • Immunology 149
  • Molecular Biology 140
  • Surgery 90
  • Rehabilitation 88
  • Biomaterials 79
Replace Yanchun Quan with:
Yanchun Quan China
Eric Hsu United States
Miguel Concha Chile
Qiyu Tang China
Behrouz Farhadihosseinabadi Iran
Ilnaz Rahimmanesh Iran
Ziying Fei China
Michael Delacher Germany
Kevin Dooley United States
Zeyad Nasa relative to Yanchun Quan China Yanchun Quan's profile →
Citations per field
00.5×1.5×1.9×
Yanchun Quan · 1×
Citations per year

Countries citing papers authored by Zeyad Nasa

Since Specialization
Citations

This map shows the geographic impact of Zeyad Nasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeyad Nasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeyad Nasa more than expected).

Fields of papers citing papers by Zeyad Nasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeyad Nasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeyad Nasa. The network helps show where Zeyad Nasa may publish in the future.

Co-authorship network of co-authors of Zeyad Nasa

This figure shows the co-authorship network connecting the top 25 collaborators of Zeyad Nasa. A scholar is included among the top collaborators of Zeyad Nasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeyad Nasa. Zeyad Nasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 15
4 11
5 19
6 37
7 26
8 81
9 7
10 12
11 5
12 12
13 15
14 16
15
A molecular Trojan horse: hijacking the bone marrow to treat autoimmune diseases.
1
16 156
17 25
18 21
19 8
20 64

About Zeyad Nasa

Zeyad Nasa is a scholar working on Hematology, Immunology and Immunology and Allergy, having authored 21 papers that have together received 538 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Rehabilitation (88 citations), Immunology (149 citations) and Biomaterials (79 citations). Zeyad Nasa has collaborated with scholars based in Australia, Austria and United Kingdom. Frequent co-authors include Heather Cleland, Frank Alderuccio, Charlotte E. Conn, Brendan Dyett, Céline Valéry, Jamie Strachan, James Chan, Ban‐Hock Toh, Ban Hock Toh and Mark Biondo. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026